PharmaKD Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

PharmaKD General Information

Description

Designer and developer of PK/PD technologies to support pharmaceutical and biotechnology industries. The company provides proprietary mass spectrometry-based platforms for automated drug metabolite profiling (DMDiscovery) and biomarker discovery (MarkerScan), as well as high throughput drug-protein binding (HT PB) assays. Its technologies are used for predicting drug efficacy, drug toxicity, and monitoring disease progression.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Acquirer
Corporate Office
  • 35 Cabot Road
  • Woburn, MA 01801
  • United States
+1 (781) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaKD Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaKD‘s full profile, request access.

Request a free trial

PharmaKD Executive Team (1)

Name Title Board Seat Contact Info
Lily Li Ph.D President
To view PharmaKD’s complete executive team members history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »